Le Lézard
Classified in: Business
Subjects: FVT, SHM

Biglari Holdings Inc. News Release


SAN ANTONIO, TX, Jan. 9, 2025 /PRNewswire/ -- Biglari Holdings (NYSE: BH.A; BH) announced today its 2025 Annual Shareholders Meeting will be held at the Majestic Theatre in San Antonio on Wednesday, April 16, 2025, at 1:00 p.m. Central Time.

About Biglari Holdings Inc.

Biglari Holdings Inc. is a holding company owning subsidiaries engaged in a number of diverse business activities, including property and casualty insurance, licensing and media, restaurants, and oil and gas.

SOURCE Biglari Holdings Inc.


These press releases may also interest you

at 23:05
Better Home & Finance Holding Company ("Better" or the "Company"), a New York-based digitally native homeownership company, today reported financial results for its fourth quarter and full year 2024. "We are pleased with the growth we achieved in...

at 22:51
Celanese Corporation ("Celanese"), a global chemical and specialty materials company, today announced the early results of offers by its direct wholly-owned subsidiary Celanese US Holdings LLC (the "Company") to purchase for cash any validly...

at 22:09
Alpha Aesthetics Partners, a leader in the medical aesthetics industry and a portfolio company of the Thurston Group, is thrilled to announce its partnership with Mint & Needle, a premier aesthetics practice based in Delaware. Founded in 2019 by...

at 20:27
Conscious Capital Growth LLC (CCG), a leading investment firm specializing in the growth and expansion of high-potential franchise brands, has announced a strategic partnership with FranDevCo, a premier franchise development firm. FranDevCo will...

at 20:19
Today, IKEA Canada hosted a groundbreaking ceremony at the location of the future IKEA Hamilton Customer Distribution Centre (CDC) and Collection point. The new unit is part of a more than $400 million investment to enhance its omnichannel journey...

at 20:15
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced its 2024 Annual Results. Business Highlights Zevor-cel was approved by China's National Medical Products...



News published on and distributed by: